Big data technology developer GeoSpock more than doubled its overall funding to $24.5m in a $12.8m round co-led by Mitsui Fudosan.

Biontech, a spinout of Johannes Gutenberg University Mainz, has received $91.5m in funding as part of the extension of a deal to develop a cancer immunotherapy candidate with Sanofi.

Cambridge big data analytics spinout GeoSpock has now raised $24.5m from investors including Cambridge Innovation Capital and Parkwalk Advisors.

Spun out of Tübingen, Justus Liebig University Gießen and Münster, Atriva Therapeutics has raised an initial $1.4m to progress next-generation antiviral drugs for conditions including influenza.

Intel Capital and Tengelmann Ventures are set to exit data processing technology developer Data Artisans, having backed its $6.3m series A round.

The genomic testing platform developer has now raised some $140m, eight years after being co-founded in EPFL's Innovation Park by researchers from EMBL, Stanford and Geneva University.

Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.

Unilever was among the existing investors that supplied $22.9m for meal kit provider Gousto, increasing its funding to about $100m to date.

Based on research from the universities of Bristol and Nottingham, Exonate has now raised $9m to develop a topical eye drop for conditions including diabetic macular edema.

Baris Guzel has been promoted to principal at BMW i Ventures, almost two years after joining the unit as a senior associate.